Paul Tudor Jones II's position in Myriad Genetics is currently worth $291 Thousand. That's 0.00% of their equity portfolio (1219th largest holding). The first Myriad Genetics trade was made in Q2 2013. Since then Paul Tudor Jones II bought shares 21 more times and sold shares on fifteen occasions. The investor's estimated purchase price is $372 Thousand, resulting in a loss of 22%.